Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study
NCT01689389 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2292
Last updated 2015-12-15
Summary
The aim of the study is to describe patient characteristics (demographic and clinical) and the patterns of use of Quetiapine XR in patients receiving the drug for the first time in real-life practice regardless the final diagnosis.
Conditions
- Schizophrenia
- Bipolar Episodes
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bruno FALISSARD, Pr · Paris
-
Pierre-Michel LLORCA, Pr · Clermont-Ferrand
Eligibility
- Min Age
- 18 Years
- Max Age
- 130 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- France
Study Locations
More Related Trials
-
Quetiapine Extended Release Depression Symptoms
NCT00640562 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Benefits of Seroquel XR in Anxiety Disorder
NCT01672554 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression
NCT00883493 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression
NCT00517387 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia
NCT00640601 ·Status: COMPLETED ·Phase: PHASE3
-
Non-interventional (NI) Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia
NCT00981123 ·Status: COMPLETED
-
Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression
NCT00926393 ·Status: COMPLETED ·Phase: PHASE4
-
A Non-interventional Study Evaluating the Clinical Benefit and Effectiveness of Quetiapine Fumarate Extended
NCT00922090 ·Status: COMPLETED
-
Effect of Quetiapine on Negative Symptoms and Cognition
NCT00305422 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone
NCT00600756 ·Status: COMPLETED ·Phase: PHASE3
-
A Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder
NCT03403790 ·Status: COMPLETED
-
Quetiapine XR for Cognitive and Functional Disability in Clinically Stable Patients With Bipolar Disorder
NCT00746421 ·Status: TERMINATED ·Phase: PHASE4
-
Non-interventional Open Label Study to Investigate the Effect of Quetiapine XR on Patient Satisfaction and Quality of Life in Patients With Schizophrenia
NCT00934726 ·Status: COMPLETED
-
EMR Data to Assess Monitoring of Patients Treated With Quetiapine
NCT01793324 ·Status: COMPLETED
-
Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current Therapy
NCT01128114 ·Status: TERMINATED ·Phase: PHASE4
-
Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in Patients With Stable Schizophrenia
NCT01213836 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat
NCT01971203 ·Status: COMPLETED ·Phase: NA
-
Quetiapine XR in Schizophrenic Patients
NCT01071135 ·Status: TERMINATED ·Phase: PHASE3
-
Bipolar Study of Seroquel XR With Pramipexole Dihydrochloride
NCT00893841 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients
NCT00789854 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine Fumarate Bipolar Maintenance Monotherapy
NCT00314184 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine in Co-Morbid Depressive and Anxiety Disorders
NCT00688818 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Seroquel vs. Risperidone in Schizophrenia
NCT00034905 ·Status: COMPLETED ·Phase: PHASE4
-
Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders
NCT00252226 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry
NCT00986167 ·Status: UNKNOWN ·Phase: PHASE4